Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
CNS Drugs 26 , 613636 (2012) Xiong, Y., Mahmood, A
Not for human or veterinary use 29 in stock Cagrilintide / Semaglutide Blend Current Batch: 11048-004 Test Date: Feb 9th, 2026 Purity: 99.771 Cagrilintide Net Content: 6.73 Semaglutide New Content: 6.03mg Cag/Sema(GLP -CS) Cap Color: Pink Product Description This blended formulation combines cagrilintide and Semaglutide, synthetic peptide analogs frequently referenced in metabolic and receptor pathway research
Product Details Volume: 3mL Composition: Sterile Water for Injection USP, 0.9% Benzyl Alcohol (preservative) Container: Multi-dose vial Sterility: Sterile filtered and sealed under clean room conditions Intended Use: Laboratory and general sterile use only Storage Instructions Store at room temperature between 68F 77F (20C 25C) Keep away from direct sunlight and heat Do not freeze Keep out of reach of children Discard 28 days after first use Disclaimer: This product is intended for laboratory and general sterile use only
In addition, human-interest senolytic dosing is typically pulsed/intermittent (a few consecutive days per cycle), so the continuous once-daily-for-16-weeks schedule shown here diverges from the typical senolytic paradigm and should be read as illustrative, not validated
Combining peptides with physical therapy and appropriate training modifications produces the best outcomes
US$ 21.29
US$ 27.68
US$ 26.89
US$ 29.33
US$ 24.66
US$ 24.95
US$ 26.90
US$ 21.79
US$ 26.07
US$ 25.53
US$ 21.53
US$ 28.41
